NASDAQ:BIAFW bioAffinity Technologies (BIAFW) Stock Forecast, Price & News $0.50 +0.15 (+42.50%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$0.21▼$0.5050-Day Range$0.22▼$0.5052-Week Range$0.03▼$4.50Volume4,306 shsAverage Volume4,433 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About bioAffinity Technologies (NASDAQ:BIAFW) StockbioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.Read More Receive BIAFW Stock News and Ratings via Email Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address BIAFW Stock News HeadlinesMay 22, 2023 | finance.yahoo.combioAffinity Technologies Presents Research Findings at CYTO 2023May 7, 2023 | americanbankingnews.combioAffinity Technologies (NASDAQ:BIAFW) Trading Down 2.4%June 10, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!April 7, 2023 | nasdaq.combioAffinity Technologies, Inc. Rings the Nasdaq Stock Market Closing BellApril 7, 2023 | nasdaq.combioAffinity Technologies, Inc. Rings the Closing BellApril 4, 2023 | bizjournals.comAfter launching IPO, promising SA biotech still chasing profitabilityMarch 24, 2023 | finance.yahoo.combioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023February 13, 2023 | finance.yahoo.combioAffinity Technologies Appoints Julie Anne Overton Director of Corporate CommunicationsJune 10, 2023 | Stansberry Research (Ad)The gold catalyst we've waited forBecause even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.January 4, 2023 | marketwatch.comBioAffinity Technologies Shares Rise 8% After Getting Notice to Allow U.S. PatentDecember 1, 2022 | finance.yahoo.combioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO MeetingNovember 14, 2022 | finance.yahoo.combioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business UpdateNovember 10, 2022 | finance.yahoo.combioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory BoardOctober 25, 2022 | finance.yahoo.combioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and AustraliaOctober 12, 2022 | finance.yahoo.combioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST ConferenceSeptember 28, 2022 | finance.yahoo.combioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6MSeptember 27, 2022 | nasdaq.combioAffinity Technologies, Inc. Warrant (BIAFW)September 14, 2022 | finance.yahoo.combioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONESee More Headlines BIAFW Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:BIAFW CUSIPN/A CIK1712762 Webwww.bioaffinitytech.com Phone210 698 5334FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$5,724.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesMs. Maria Zannes J.D. (Age 66)Founder, Pres, CEO & Director Comp: $227.2kDr. Vivienne I. Rebel M.D. (Age 57)Ph.D., Exec. VP and Chief Medical & Science Officer Comp: $236.59kMr. Michael Edwards CPA (Age 55)M.B.A., Chief Financial Officer Mr. Xavier T. Reveles M.S.VP of OperationsMr. Timothy P. Zannes J.D. (Age 69)Exec. VP, Sec. & Gen. Counsel Dr. William Bauta Ph.D.Sr. VP of R&D - TherapeuticsMore ExecutivesKey CompetitorsStar EquityNASDAQ:STRRP111NASDAQ:YIAclarionNASDAQ:ACONWAinosNASDAQ:AIMDWAlpha Tau MedicalNASDAQ:DRTSWView All Competitors BIAFW Stock - Frequently Asked Questions How have BIAFW shares performed in 2023? bioAffinity Technologies' stock was trading at $0.42 at the start of the year. Since then, BIAFW stock has increased by 19.7% and is now trading at $0.5029. View the best growth stocks for 2023 here. What is bioAffinity Technologies' stock symbol? bioAffinity Technologies trades on the NASDAQ under the ticker symbol "BIAFW." How do I buy shares of bioAffinity Technologies? Shares of BIAFW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is bioAffinity Technologies' stock price today? One share of BIAFW stock can currently be purchased for approximately $0.50. How can I contact bioAffinity Technologies? The official website for the company is www.bioaffinitytech.com. The company can be reached via phone at 210 698 5334. This page (NASDAQ:BIAFW) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.